Stanley Druckenmiller
BSX icon

Stanley Druckenmiller’s Boston Scientific BSX Stock Holding History

Stanley Druckenmiller’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-1,000,000
Closed -$9.27M – 29
2013
Q2 		$9.27M Buy
+1,000,000
New +$8.48M 1.38% 16

Other funds holding BSX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return
Diamond Hill Capital Management
Diamond Hill Capital Management Columbus, Ohio $16B AUM 4.15% 1-Year Est. Return

Stanley Druckenmiller's BSX Position: Q3 2013 in Review

Stanley Druckenmiller sold out of Boston Scientific (BSX) in Q3 2013, closing a stake of 1,000,000 shares — an estimated $9.27M sold.

Stanley Druckenmiller first reported a position in BSX in Q2 2013 and held it in 1 quarter. The position peaked at $9.27M in Q2 2013. 419 funds tracked by Wall St. Rank hold BSX as of Q3 2013.

  • Stanley Druckenmiller reported no remaining Boston Scientific position as of Q3 2013 after selling out during the quarter.
  • Stanley Druckenmiller sold 1,000,000 Boston Scientific shares in Q3 2013, an estimated $9.27M.
  • Stanley Druckenmiller first reported a position in Boston Scientific in Q2 2013 and held it in 1 quarter.
  • Stanley Druckenmiller's Boston Scientific position peaked at $9.27M in Q2 2013.
  • 419 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2013.

Based on Duquesne Family Office's 13F filing for Q3 2013, filed 14 Nov 2013.